Skip to main content
. 2021 Oct 24;148(2):321–330. doi: 10.1007/s00432-021-03818-w

Table 4.

Characteristics of mutation units types of EGFR in 802 NSCLC patients analysis by NGS

Exons Sites Mutations Amino acid sequence changes Unit positive case (n) Unit point mutation rate (%) Total mutation rate of exon (%) Composition ratio (%)
G719X 11 1.4 1.9 3.5
G719A 2156G>C
18 3 G719S 2155G>A
G719C 2155G>T
E709 4 0.5
19 19 19del- 124 15.5 15.5 29.2
E746-A750del 2236-2250del
S752-I759del 2254-2277del
The rest are not listed
20 5 T790M 2369C>T 31 3.9 6.9 13.0
S768I 2303G>T 4 0.5
20Ins 16 2.0
The rest are not listed 4 0.5
21 2 L858R 2573T>G 156 19.5 20.9 49.1
L861Q 2582T>A 11 1.4
Rare mutation 5 5 0.6 1.2
 5 p.R547*
 17 p.R677C
 27 p.E1079K
 15 p.C624Y
Exon28_Intron4 EGFR-PPP1R17
Gene amplification 58 7.2 13.7

The mutation of EGFR gene in patients with advanced NSCLC was detected by ARMS-PCR. Unit point mutation rate = the number of mutations per unit point/total number of mutations

NSCLC non-small cell lung cancer, EGFR epidermal growth factor receptor, § include 209 single-site mutation patients and 131 multiple locus mutation patients